|
| |
| KLSE: OPTIMAX (0222) | OPTIMAX HOLDINGS BERHAD | ACE : Health Care |
| Last Price | Today's Change | Day's Range | Trading Volume |
| 1.00 | 0.00 (0.00%) | 1.00 - 1.04 | 2,379,000 |
| Trade this stock with T+7 trading account. Find out more. |
Financials
Market Cap: 270 Million
| Latest Quarter: 30-Sep-2020 [#3]
| |||||||||||||||||||||||||||||||||||
T4Q Result ( EPS: 2.15, P/E: 46.53 )
| Annualized Result ( EPS: 1.76, P/E: 56.82 )
|
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click here to modify the Visible Columns.
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
| 31-Dec-2020 | 26-Nov-2020 | 30-Sep-2020 | 3 | 18,192 | 3,959 | 2,928 | 2,595 | - | 45,900 | - % | 16.09% | 5.65% | 270,000 | 6.74 | 6.74 | 0.96 | 0.96 | 0.00 | 0.00 | 0.1700 | 0.17 |  4,225.00%
| 15.90% | 30-Sep-2020 | 0.795 | 11.80 | 82.72 | 4.68 | 1.21% | 0.00% | 26-Nov-2020 | 0.765 | 11.35 | 79.60 | 4.50 | 1.26% | 0.00% |
| 31-Dec-2020 | 27-Aug-2020 | 30-Jun-2020 | 2 | 9,539 | 177 | 118 | 60 | - | 23,999 | - % | 1.24% | 0.25% | 200,000 | 4.77 | 3.53 | 0.03 | 0.02 | 0.00 | 0.00 | 0.1200 | 0.09 | -93.40%
| -97.60% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | 27-Aug-2020 | 0.79 | 16.56 | 2,633.33 | 6.58 | 0.04% | 0.00% | |
| 31-Dec-2020 | 14-Aug-2020 | 31-Mar-2020 | 1 | 13,078 | 1,655 | 1,107 | 909 | - | 2,357,099 | - % | 8.46% | 0.04% | 270,000 | 4.84 | 4.84 | 33.67 | 33.67 | 0.00 | 0.00 | 8.7300 | 8.73 | -59.40%
| -39.36% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | ||
| 31-Dec-2019 | 30-Sep-2019 | 3 | 16,069 | 3,609 | 2,493 | 2,239 | - | - | - % | 15.51% | - % | 269,759 | 5.96 | 5.95 | 0.83 | 0.83 | 0.00 | 0.00 | - | - | -10.55%
| - % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | |||
| 31-Dec-2019 | 30-Jun-2019 | 2 | 16,163 | 3,949 | 2,709 | 2,503 | - | - | - % | 16.76% | - % | 200,240 | 8.07 | 5.99 | 1.25 | 0.93 | 0.00 | 0.00 | - | - | 66.98%
| - % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | |||
| 31-Dec-2019 | 31-Mar-2019 | 1 | 13,581 | 2,372 | 1,744 | 1,499 | - | - | - % | 12.84% | - % | 2,699 | 503.01 | 5.03 | 55.52 | 0.56 | 0.00 | 0.00 | - | - | - % | - % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00% | |||
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
 sharkdododo found some valuation for your reading! https://jawplace.com/optimax-almost-perfect-vision/ 21/08/2020 11:21 PM su1801 Not to worry invest here....this counter potential stock...my personal TP rm1.00, 1.20, 1.55 and 2.00 but to hold mid term 22/08/2020 5:29 PM su1801 This counter already survive more 20 years...health care specialty on eye disorder....For sure profit.... 22/08/2020 5:30 PM Thespike Looks very well supported. Will fly to Rm 1 once operator has collected enough 02/09/2020 5:09 PM Long George TP RM1.30, still cheap https://klse.i3investor.com/blogs/kenangaresearch/2020-09-03-story-h1513312332-Optimax_Holdings_Eyeing_Expansion_to_Boost_Growth.jsp 03/09/2020 2:00 PM lch90 Shy shy Masuk a bit see. I like long term investment with good fundamental company 03/09/2020 4:28 PM hockmenglai Optimax Holdings (OPTIMAX MK/BUY/RM0.81/Target Price: RM1.10) 1H20: Temporary Glitches By MCO; Good Growth Trajectory Ahead *What’s New* • *ACC expansion drives organic growth.* Optimax’s expansion plan includes upgrading both Klang and Seremban branches to Ambulatory Care Centre (ACC) in order to carry out cataract and refractive surgical procedures. Management sees the potential annual revenue generation from both ACCs to be closed to RM10m-12m from 2021F onwards (2019: RM1.3m). We gathered that Optimax’s organic growth comes from the growing number of ACC. • *Earnings recovery in 2H20*. While 1H20 earnings dropped 77% yoy amid COVID-19 impact, management sees surgeries picked up encouragingly with surgeries conducted for the month of June and July have outpaced the average monthly level seen in 2019. Taking cues from management inputs and records in the past, we believe the healthy underlying demand for ophthalmologist services could pave the way for an earnings recovery in 2H20. • *Good growth prospect with a 24% earnings CAGR for 2019-22F*. This will be underpinned by: a) additional revenue stream from the Seremban and Klang ACC, b) an average 23% revenue growth from both cataract and laser operations, and c) established market presence. Optimax is the key beneficiary of the growing trend of aging and myopic populations. • *Maintained BUY with a higher target price of RM1.10* in tandem with earnings upgrade (raised 18% and 14% for 2021F-22F earnings). We also ascribed a higher 2021F PE from 20x to 25x. This is based on regional 2016-19 average PEG of 1.5x, and a 30% discount from the implied PE of 36x. Since our initiation with BUY, share price soared up 270% from its IPO price and 13% from our previous TP. That said, we believe the market might not have sufficiently priced in for its scarcity premium given its good value proposition. Please see the attached file link: https://research.uobkayhian.com/content_download.jsp?id=58627&h=3beeb3d3d3c61910b3b8822f439fc4d4 07/09/2020 9:47 AM lch90 Klci goes up this share no movement. Klci down, this counter first to go down 11/09/2020 2:40 PM chiahs Cytew-> Buy Vol up these 2 days, a good sign to move higher, even better if have some positive news to support :) 14/12/2020 5:28 PM Thespike From the momentum, it is trending higher with the short term of RM 1 easily breached. Fundamentally a very sound Company with specialised business not easily replicated. 23/12/2020 8:10 PM Lasereye2020 Just sold my lots, because the revenue will be bad when they release the 2020 reports, the number of cataract surgery has gone down by 40% and it is giving discounted prices (RM$2,800) to fight Top Vision and Vista. 28/12/2020 11:04 AM Thespike Definitely will hit rm 1 in Jan if not next week. Very little free float in the market & easy for operator to push share higher. 03/01/2021 12:18 AM make_money_enough Technically will rebound by tomorrow. However still depend on the market sentiment. 25/01/2021 9:27 PM  |
|
